Benjamin L Lampson

7PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Biologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 07, 2024
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

Matthew S Davids, Christine E Ryan, Benjamin L Lampson

|Oct 31, 2022
Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia.

Benjamin L Lampson, Aditi Gupta, Svitlana Tyekucheva

|Feb 06, 2021
Targeting oncoproteins with a positive selection assay for protein degraders.

Vidyasagar Koduri, Leslie Duplaquet, Benjamin L Lampson

|Apr 11, 2019
Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia.

Benjamin L Lampson, Haesook T Kim, Matthew S Davids

|Jun 02, 2016
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity.

Benjamin L Lampson, Siddha N Kasar, Tiago R Matos

Pageof 2

Frequent Collaborators

3 joint publications

Jennifer R Brown

2 joint publications

Joshua Fein

2 joint publications

Svitlana Tyekucheva

1 joint publications

Elizabeth A Morgan